Another AI Star Is Born: 'ChatGPT for Doctors' OpenEvidence Reportedly Valued at $15 Billion
Summary
Business Insider reports that OpenEvidence, which provides AI search for doctors, has raised $250 million from several hospital systems and Andreessen Horowitz, lifting its valuation to $15 billion — up from $12 billion in a January round. The Miami-based company has raised over $1 billion in the past year from investors including Thrive Capital, DST, GV, Kleiner Perkins, Sequoia and Nvidia, and a person familiar said it may consider a sale, noting that compute supply could tighten if anti-AI sentiment blocks datacenter expansion.
Bubble analysis
This is direct evidence on the money side of the AI bubble debate: a four-year-old medical AI app with no disclosed revenue saw its valuation jump from $12 billion to $15 billion in eight months and raised over $1 billion in a year, showing private capital is still flooding into AI-branded companies. But it is a single funding round, so it says nothing about whether AI spending industry-wide has outrun AI revenue — supporting evidence for the bubble case, not proof of it.
Related signals
linked by shared tags
- Valor, Atreides, and Sequoia back AI startup Flow Engineering at $750M valuation#valuation#funding
- Racing to List Before Thanksgiving: Anthropic Said to Seek IPO as Early as Mid-November#valuation
- Nvidia-Backed Firmus Plans Australian IPO at $30 Billion Target Valuation#funding
- Bank of England Governor: "Must Prepare for Market Shock If AI Bubble Bursts"#valuation
- Photon held a funeral for mobile apps. Now it has $4.5M to help replace them with agents.#funding